Foresite Capital Management Vi LLC Edgewise Therapeutics, Inc. Transaction History
Foresite Capital Management Vi LLC
- $224 Billion
- Q4 2024
A detailed history of Foresite Capital Management Vi LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 585,000 shares of EWTX stock, worth $14.9 Million. This represents 6.96% of its overall portfolio holdings.
Number of Shares
585,000Holding current value
$14.9 Million% of portfolio
6.96%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
214Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$381 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$226 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$156 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$153 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$127 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.6B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...